Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed.

Subjects

Subjects :

Female
Humans
Male
Antibodies, Monoclonal, Humanized therapeutic use
Escherichia coli Infections complications
Hemolytic-Uremic Syndrome etiology
Hemolytic-Uremic Syndrome therapy
Plasma Exchange
Shiga-Toxigenic Escherichia coli pathogenicity

Details

Language :

English

ISSN :

1460-2385

Volume :

27

Issue :

10

Database :

MEDLINE

Journal :

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Publication Type :

Report

Accession number :

23114892

Full Text :

https://doi.org/10.1093/ndt/gfs456